CHDI FOUNDATIONCHDI

Accelerating Therapeutic Development for Huntington's Disease

  • Preclinical research
  • Scientific Publications
  • Community Resources
    • Materials
      • Research tools & reagents
      • Mouse Models
      • Clinical biorepository
    • Data sharing & infomatics
      • Preclinical informatics: HDinHD
    • Funding & partnerships
      • Academic Proposals
      • External Partnership Proposals
    • HD expertise & guidance
      • Independent Statistical Standing Committee
      • Clinical outcomes: Rating scales
      • Field guide to HD mouse models
  • News & Video
    • News
    • HD Therapeutics Conference
      • 2025 Presentations
      • 2024 Presentations
      • 2023 Presentations
      • 2022 Presentations
      • 2021 Presentations
      • 2020 Presentations
      • 2019 Presentations
      • 2018 Presentations
      • 2017 Presentations
      • 2016 Presentations
      • 2015 Presentations
      • 2014 Presentations
      • 2013 Presentations
      • 2012 Presentations
      • 2011 Presentations
    • Postcards
    • Events
  • About Us
    • The Foundation
    • People
    • Policies
      • Data, Reagents, and Biomaterials Sharing Policy
      • Publication Policy
      • Reimbursement of Publication Costs
      • Financial Support for Conferences, Meetings, or Workshops
      • Academic Overhead
      • Academic Salary Limits
      • Leave of Absence Policy
      • Eligible Personnel
  • Preclinical research
  • Scientific Publications
  • Community Resources
    • Materials
      • Research tools & reagents
      • Mouse Models
      • Clinical biorepository
    • Data sharing & infomatics
      • Preclinical informatics: HDinHD
    • Funding & partnerships
      • Academic Proposals
      • External Partnership Proposals
    • HD expertise & guidance
      • Independent Statistical Standing Committee
      • Clinical outcomes: Rating scales
      • Field guide to HD mouse models
  • News & Video
    • News
    • HD Therapeutics Conference
      • 2025 Presentations
      • 2024 Presentations
      • 2023 Presentations
      • 2022 Presentations
      • 2021 Presentations
      • 2020 Presentations
      • 2019 Presentations
      • 2018 Presentations
      • 2017 Presentations
      • 2016 Presentations
      • 2015 Presentations
      • 2014 Presentations
      • 2013 Presentations
      • 2012 Presentations
      • 2011 Presentations
    • Postcards
    • Events
  • About Us
    • The Foundation
    • People
    • Policies
      • Data, Reagents, and Biomaterials Sharing Policy
      • Publication Policy
      • Reimbursement of Publication Costs
      • Financial Support for Conferences, Meetings, or Workshops
      • Academic Overhead
      • Academic Salary Limits
      • Leave of Absence Policy
      • Eligible Personnel

December 19, 2018

New Enroll-HD clinical dataset now available

December 18, 2018 – A new data cut from the Enroll-HD observational study, named periodic dataset 4 (PDS4), was made available for download to any interested researcher on December 14, 2018. PDS4 comprises data from 15,301 participants, representing approximately 80% of the total number of participants. The PDS4 file structure is the same as the previous dataset, PDS3 Plus, and contains additional longitudinal data from 3,802 Enroll-HD participants who also took part in the REGISTRY study. There is also clinical data for some participants collected in ad hoc visits prior to their Enroll-HD/REGISTRY study participation. As a guide to the longitudinal nature of PDS4, participants who are only taking part in Enroll-HD have up to 6 visits, those in Enroll-HD plus REGISTRY have up to 20 visits, and those who were part of Enroll-HD and REGISTRY plus ad hoc data have up to 32 visits.

Supporting documentation for PDS4 has been updated, including the Data Handling Manual, the Data Dictionary, and the Annotated CRF. In addition, a Change Log provides a high-level description of the changes made from PDS3 Plus to PDS4. Several user guides are available to help use the data efficiently. Please read through this documentation thoroughly.

Post navigation

← Alex Borchers PhD, April 16, 1961 – August 3, 2019 CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics →
Connect with CHDI

Send Feedback

We appreciate any comments or questions on this page—our goal is to make this concise and helpful.

Join Our Mailing List
Terms of Use
Privacy Policy
Cookie Policy
Creative Commons License
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 Unported License.

Click to read a letter from Robert Pacifici, CHDI CSO, regarding COVID-19